Purine signaling and potential new therapeutic approach: Possible outcomes of NTPDase inhibition

Current Drug Targets

Volumn 3, Issue 3, 2002, Pages 229-245

  Gendron, F P ^a   Benrezzak, O ^a   Krugh, B W ^a   Kong, Q ^a   Weisman, G A ^a   Beaudoin, A R ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BUTYLAMINO ADENOSINE TRIPHOSPHATE; 8 BUTYLETHER ADENOSINE TRIPHOSPHATE; 8 BUTYLTHIO ADENOSINE TRIPHOSPHATE; 8 BUTYLTHIOETHER ADENOSINE TRIPHOSPHATE; 8 CYCLOHEPTYL THIOETHER ADENOSINE TRIPHOSPHATE; 8 ETHYL THIOETHER ADENOSINE TRIPHOSPHATE; 8 HEXYL THIOETHER ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE DERIVATIVE; APYRASE; BG 0136; CD39 ANTIGEN; CIBACRON BLUE F3GA; EVANS BLUE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; NUCLEOTIDASE; NUCLEOTIDE DERIVATIVE; PURINE; PURINE DERIVATIVE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIMIDINE DERIVATIVE; SURAMIN; TRYPAN BLUE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ENZYME INHIBITOR;

CELL FUNCTION; CHANNEL GATING; CONTROLLED STUDY; DRUG HYDROLYSIS; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; MEDICAL RESEARCH; NONHUMAN; OUTCOMES RESEARCH; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN;

ANIMAL; APYRASE; ENZYME INHIBITORS; HUMAN; PURINES; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS;

EID: 0036001053     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450023347713     Document Type: Review

References (196)

1. Purine and pyrimidine metabolism in man X